by chodges | Feb 27, 2024 | News
Optibrium Launches a Metabolism Prediction Software Platform Tailored to DMPK Scientists Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery ...
by Katie Strickland | Feb 26, 2024 | News
ACS Spring 2024 – Many Flavors of Chemistry New Orleans, LA, USA. Join Optibrium at the ACS Spring meeting 2024 where we are delighted to be presenting the below talks. Matt Segall will be presenting ‘Predicting in vivo PK from limited in vitro ADME data...
by chodges | Feb 15, 2024 | News
Optibrium enables collaborative design in its StarDrop platform The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within...
by chodges | Dec 7, 2023 | News
Optibrium’s quantum mechanics and machine learning methods predict routes of drug metabolism Peer-reviewed study published in Xenobiotica describes an innovative new method that predicts the routes and products of Phase I and II metabolism with high sensitivity...
by chodges | Oct 23, 2023 | News
Optibrium introduces cloud-based version of StarDrop drug discovery platform Cloud-based version of StarDrop retains all the functionality and interactivity of desktop version with improved accessibility and lower total cost of ownership for customers Optibrium...
by Katie Strickland | Oct 14, 2023 | News
Models for success: improving drug metabolism prediction Out now in Drug Target Review, Optibrium’s Director of Computational Chemistry, Dr Peter Hunt discusses why early in silico metabolism prediction is crucial to mitigate the problem of clinical-stage...